Cytek Corp (CTKB) Narxning foydaga nisbati

Cytek Bio (CTKB) korporativ emblemasi va logotipi

Cytek Biosciences, Inc. (CTKB) uchun sensorlarni ishlab chiqish xarajatlari ushbu grafikda kompaniyaning P/E koeffitsiyenti o'zgarishlari orqali ko'rinadigan xavflarni yuzaga keltirmoqda, bunda parametr qiymati -9.60 ni tashkil etadi. Geopolitik to'siqlar tsitometrlarning eksportini cheklasa-da, ko'p rangli tizimlar savdosining o'sishi va reagentlarga bo'lgan talab barqaror daromadni ta'minlab, aktivning joriy bozor qiymatini qo'llab-quvvatlamoqda.

CTKB Cytek Biosciences: Narxning foydaga nisbati 04.07.2022 - 10.11.2026 oraligʻida

Cytek Biosciences, Inc. kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:CTKB cytekbio.com
Cytek Biosciences, Inc. ishlab chiqargan mahsulot

Bozor Cytek Biosciences, Inc. (CTKB) ning salohiyatini uning noyob spektral profiltexnologiyasi prizmasi orqali baholaydi va biznes qiymatini shakllantirilgan pul oqimiga nisbatan aniqlaydi. Kompaniyaning P/E grafigini tahlil qilish orqali investor bozor kapitalizatsiyasining sof foydaga nisbatini ko'rishi mumkin, bu esa hujayralar tahlilidagi innovatsiyalar uchun to'langan premiumni aniqlash va aktivning umumiy barqarorligini baholash imkonini beradi.

Raqobatdosh kompaniyalar

P/E multiplikatori agilent.com|Narxning foydaga nisbati Quest Diagnostics Incorporated (DGX)|Narxning foydaga nisbati ILMN (Illumina Inc)|Cologuard - Narx-foyda koeffitsiyenti|Revvity Corp (RVTY) - Kapitalizatsiyaning foydaga nisbati|BIO - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati anbio.com NNNN|SHC: P/E multiplikatori|QDEL - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati OPKO Corp|caredx.com (CDNA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori MRVI|Narx-foyda koeffitsiyenti fulgentgenetics.com FLGT|Standard BioTools - Narx-foyda koeffitsiyenti|OraSure Technologies, Inc. (OSUR) - Kapitalizatsiyaning foydaga nisbati|XGN: Narx-foyda koeffitsiyenti|MDxHealth, Inc. - Bozor narxining sof foydaga nisbati|LUCD: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Prenetics (PRE)|Narxning foydaga nisbati Insight Molecular Diagnostics, Inc.|P/E multiplikatori Trinity Biotech Corp|Narx-foyda koeffitsiyenti PRPH (ProPhase)|AIMD (Ainos Corporation) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CODX (Co-Diagnostics, Inc.)|heartsciences.com - Narxning foydaga nisbati|Biomerica - P/E multiplikatori|Biznesning o‘zini qoplash muddati Cardio Diagnostics CDIO|Onconetix Corp (ONCO) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Virax Biolabs Corp (VRAX)|Narxning foydaga nisbati Bluejay Diagnostics|aspirawh.com (AWH) - Biznesning o‘zini qoplash muddati|P/E multiplikatori AXDX|Narx-foyda koeffitsiyenti CENTOGENE CNTG|P/E multiplikatori ENZ (Enzo Biochem)|Biznesning o‘zini qoplash muddati Fresh2 Group Ltd (FRES)|GTG Labs - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati 23andme.com|Psychemedics Corporation (PMD) - Narxning foydaga nisbati